A18_-_DEC_Acknowledgment.pdf

PDF 71 KB Posted

Attached to
Request for Proposals - Phase I Clinical Trials Federal contract opportunity
Solicitation number
75N95024R00086
Issued by
Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse

About this file

This document is a Determination of Exceptional Circumstances Acknowledgment Form related to a Request for Proposals (RFP) for Phase I Clinical Trials. The RFP is issued by the National Institutes of Health (NIH) National Institute on Drug Abuse for the development of small molecule and biologics therapeutics. The acknowledgment form states that the NIH has approved the use of HHSAR Clauses 352.227-11 and 352.227-14, which cover patent rights and data rights under exceptional circumstances, to be included in the resulting contract(s). Any prospective offeror must certify their intent to comply with the terms of these clauses in order to be considered for award.

View the file

Other files for this federal contract opportunity

Other files attached to Request for Proposals - Phase I Clinical Trials, newest first.
File Type Posted
Sol_75N95024R00086_Amd_0003.pdf PDF
RFP_75N95024R00086_Amnd_0003_0003.pdf PDF
Sol_75N95024R00086_Amd_0002.pdf PDF
RFP_75N95024R00086_Amnd_0002_0002.pdf PDF
Sol_75N95024R00086_Amd_0001.pdf PDF
A15_-_SBCX_Industry_Subcontracting_Guide.pdf PDF
A3_-_Proposal_Intent_Response_Form.pdf PDF
A22_-_PHS_Human_Subjects_and_Clinical_Trials_Information_Form-H.pdf PDF
A7_-_IDIQ_Contract_Statement_of_Work__080724.pdf PDF
A10_-_Sample_TORFP_3_SOW_-_SADMAD_Study_080624.pdf PDF
A12_-_Summary_of_Related_Activities.pdf PDF
A11_-_Additional_Technical_Proposal_Instructions.pdf PDF
A19_-_NIH(RC)-1_-_Invoice_Financing_Request_Instructions.pdf PDF
A1_-_RFP_Cover_Letter_081924_signed.pdf PDF
A16_-_Wage_Determination.pdf PDF
A4_-_Proposal_Summary_and_Data_Record__NIH-2043.pdf PDF
A13_-_Technical_Proposal_Cost_Summary.pdf PDF
A5_-_Offeror_s_Points_of_Contact.pdf PDF
A9_-_Sample_TORFP_2_SOW_-_SAD_Study_080624.pdf PDF
Sol_75N95024R00086.pdf PDF
A20_-_NIDA_Supplemental_Billing_Instructions.pdf PDF
A23_-_Protection_of_Human_Subjects_Assurance_Identification.pdf PDF
A14_-_Breakdown_of_Proposed_Estimated_Costs.xlsx XLSX spreadsheet
A2_-_Packaging_and_Delivery_of_Proposals_for_Use_with_the_NIH_eCPS_website.pdf PDF
A8_-_Sample_TORFP_1_SOW_-_Kickoff_Meeting_PMP.pdf PDF
A24_-_Public_Health_Surveillance_Exclusion_Request.pdf PDF
A17_-_Disclosure_of_Lobbying_Activities__OMB_Form_SF-LLL.pdf PDF
A6_-_Section_K_-_Representations__Certifications__and_Other_Statements_of_Offerors_May_2024.docx DOCX document
A21_-_NIH(RC)-2_-_Fixed-Price_Invoice_Instructions.pdf PDF
Show all 29

On GovTribe

Work with this file on GovTribe

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

DETERMINATION OF EXCEPTIONAL CIRCUMSTANCES

ACKNOWLEDGEMENT FORM

A Determination of Exceptional Circumstances to incorporate HHSAR Clauses 352.227- 11 and HHSAR 352.227-14 has been approved for use by the NINDS for this acquisition. The edited HHSAR Clauses at 352.227-11, Patent Rights-Exceptional Circumstances and 352.227-14, Rights in Data – Exceptional Circumstances, which are included in full text in Article I.4. of the uniform contract schedule of this RFP, will be made a part of any resultant contract(s) under this solicitation. As such, any prospective offeror, must certify and agree that to be considered for award and if selected for award a contract that they do accept and will abide by the terms and conditions of these clauses.

The undersigned hereby acknowledges understanding of and intent to comply with the terms and conditions of HHSAR Clause 352.227-11, Patent Rights-Exceptional Circumstances (Sept. 2014) and HHSAR Clause 352.227-14, Rights in Data- Exceptional Circumstances (Sept. 2014).

Signature of authorized official Date undefined_2:

File details come from the government source that posted it. Updated .